Earnings Releases·Nov 12, 2026, 6:23 AM ET

Vylor — Q3 2026 Earnings Summary

Q3 2026 pro forma net sales declined 1% year-over-year to $938 million, while GAAP pro forma loss from continuing operations widened to $480 million from $391 million in the prior year period; however, YTD 2026 pro forma net sales rose 4% to $8.53 billion, and Adjusted Pro Forma Operating EBITDA grew 8% year-over-year to $2.66 billion.
The company reaffirmed full-year 2026 guidance for Adjusted Pro Forma Operating EBITDA of approximately $2.8 billion and Adjusted Pro Forma Operating EPS between $2.25 and $2.35, alongside a 2029 Financial Framework targeting $3.3 billion to $3.7 billion in operating EBITDA and 30% margins.
Strategic capital allocation includes a newly authorized $3 billion multi-year share repurchase program with no expiration and a quarterly dividend of $0.13 per share, following the company's separation from Corteva, Inc. on October 1, 2026.
Management outlined a $19 billion technology pipeline featuring 12 platform launches over the next decade, including gene-edited corn and Xpedite™ wheat, while projecting licensing income to exceed $1 billion by 2035 via the Vylor One business.